Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pacific Biosciences of California Inc PACB

Technology Scientific & Technical Instruments
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing... see more

Recent & Breaking News (NDAQ:PACB)

PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance

PR Newswire April 16, 2024

Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes

PR Newswire March 27, 2024

PacBio Grants Equity Incentive Award to New Employee

PR Newswire March 22, 2024

PacBio Announces PureTarget(TM) Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions

PR Newswire March 12, 2024

PacBio to Present at Upcoming Investor Conferences

PR Newswire February 26, 2024

PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results

PR Newswire February 15, 2024

Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch

PR Newswire February 13, 2024

PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale

PR Newswire February 5, 2024

PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024

PR Newswire January 25, 2024

PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions

PR Newswire January 15, 2024

PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively

PR Newswire January 8, 2024

PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire December 27, 2023

PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors

PR Newswire December 11, 2023

PacBio to Present at Upcoming Investor Conferences

PR Newswire November 9, 2023

PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders

PR Newswire November 2, 2023

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible

PR Newswire November 1, 2023

PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications

PR Newswire October 31, 2023

PacBio Announces Third Quarter 2023 Financial Results

PR Newswire October 30, 2023

PacBio Announces Appointment of David Meline to Board of Directors

PR Newswire October 16, 2023

PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023

PR Newswire October 12, 2023